We are live on
!
Find out more
MCM
McRae Capital Management Portfolio holdings
AUM
$508M
1-Year Est. Return
14.21%
This Fund
S&P 500
This Quarter
Est. Return
-4.38%
1 Year Est. Return
+14.21%
3 Year Est. Return
+59.23%
5 Year Est. Return
+71.2%
10 Year Est. Return
+359.88%
AUM
$338M
AUM Growth
-$14.1M
(-4%)
Cap. Flow
+$6.11M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
47.01%
Holding
99
New
3
Increased
30
Reduced
33
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$6.43M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$4.62M |
| 3 |
Public Service Enterprise Group
PEG
|
+$4.47M |
| 4 |
PRFT
Perficient Inc
PRFT
|
+$2.92M |
| 5 |
Fortrea Holdings
FTRE
|
+$2.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$6.84M |
| 2 |
Skyworks Solutions
SWKS
|
+$3.7M |
| 3 |
Labcorp
LH
|
+$2.34M |
| 4 |
Quanta Services
PWR
|
+$468K |
| 5 |
Truist Financial
TFC
|
+$466K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.33% |
| 2 | Healthcare | 20.66% |
| 3 | Industrials | 11.51% |
| 4 | Financials | 11.32% |
| 5 | Consumer Discretionary | 9.93% |
Similar funds
OWP
MCM
MC
OA
MCA
WMG
PWMG
BA
McRae Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, McRae Capital Management held 99 positions worth $338M, down 4% from $352M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
McRae Capital Management's Q3 2023 filing shows 3 new, 30 increased, 33 reduced and 5 closed positions. Its largest new stake was Fortrea Holdings: 68,740 shares worth $1.97M. The largest sale was Zebra Technologies, an estimated $6.84M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.
- McRae Capital Management's largest Q3 2023 buy was Fortrea Holdings: 68,740 shares worth $1.97M.
- McRae Capital Management added most to UnitedHealth in Q3 2023, an estimated $6.43M increase.
- McRae Capital Management's biggest Q3 2023 reduction was Zebra Technologies, cutting an estimated $6.84M.
- McRae Capital Management fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $317K.
- McRae Capital Management's ten largest holdings make up 47% of its $338M portfolio in Q3 2023.
- McRae Capital Management opened 3 new positions and closed 5 in Q3 2023.
- McRae Capital Management's portfolio value fell 4% quarter-over-quarter to $338M.
Based on McRae Capital Management's 13F filing for Q3 2023, filed 17 Oct 2023.